Verition Fund Management
IMA

Verition Fund Management’s ImageneBio Inc IMA Stock Holding History

Verition Fund Management’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-11,275
Closed -$223K – 3346
2024
Q2 		$223K Sell
11,275
-83,282
-88% -$1.47M ﹤0.01% 2527
2024
Q1 		$1.61M Sell
94,557
-15,643
-14% -$285K 0.01% 1339
2023
Q4 		$2.61M Sell
110,200
-33,274
-23% -$1.08M 0.02% 712
2023
Q3 		$7.45M Buy
143,474
+55,048
+62% +$3.31M 0.09% 298
2023
Q2 		$6.96M Sell
88,426
-44,569
-34% -$3.2M 0.09% 286
2023
Q1 		$5.51M Buy
132,995
+1,297
+1% +$59.6K 0.08% 336
2022
Q4 		$4.2M Buy
131,698
+23,427
+22% +$749K 0.07% 370
2022
Q3 		$4.61M Buy
108,271
+23,113
+27% +$1.34M 0.05% 451
2022
Q2 		$4.53M Buy
+85,158
New +$4.7M 0.09% 297

Other funds holding IMA

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
AI
Acuitas Investments Seattle, Washington $1.43M AUM 17.52% 1-Year Est. Return

Verition Fund Management's IMA Position: Q3 2024 in Review

Verition Fund Management sold out of ImageneBio Inc (IMA) in Q3 2024, closing a stake of 11,275 shares — an estimated $223K sold.

Verition Fund Management first reported a position in IMA in Q2 2022 and held it in 9 quarters. The position peaked at $7.45M in Q3 2023. 57 funds tracked by Wall St. Rank hold IMA as of Q3 2024.

  • Verition Fund Management reported no remaining ImageneBio Inc position as of Q3 2024 after selling out during the quarter.
  • Verition Fund Management sold 11,275 ImageneBio Inc shares in Q3 2024, an estimated $223K.
  • Verition Fund Management first reported a position in ImageneBio Inc in Q2 2022 and held it in 9 quarters.
  • Verition Fund Management's ImageneBio Inc position peaked at $7.45M in Q3 2023.
  • 57 funds tracked by Wall St. Rank held ImageneBio Inc as of Q3 2024.

Based on Verition Fund Management's 13F filing for Q3 2024, filed 14 Nov 2024.